Rhodes Technologies is an API manufacturer, which core business is controlled substances (CI-V) including opiates and cannabinoids, as well as innovative APIs. Rhodes operates a multi-purpose, FDA-registered and DEA certified plant, which has one of the largest hydrogenation facilities in the US North-East, and has a complete range of active pharmaceutical ingredients production capabilities, including process development, synthesis, preparative chromatography, drying, plus advanced micronization suites with state-of-the-art jet mills. Broad range of the equipment allows Rhodes to perform wide variety of chemical reactions and supply its customers from kilograms to tons of cGMP materials in a timely fashion.